TransMedics Group, Inc. Gains 40.33%

Wed, May 04, 2022 at 05:30 PM

TransMedics Group, Inc. (TMDX:NASDAQ) soared at $30.69, a gain of 40.3%. The stock appeared on our News Catalysts scanner on Tue, May 03, 2022 at 06:32 PM in the 'EARNINGS' category. From Wed, Apr 20, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About TransMedics Group, Inc. (TMDX:NASDAQ)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Top 10 Gainers:

Rail Vision Ltd. (RVSN:NASDAQ), 62.41%
TransMedics Group, Inc. (TMDX:NASDAQ), 40.33%
Aclarion Inc. (ACON:NASDAQ), 36.63%
Alaunos Therapeutics Inc Com (TCRT:NASDAQ), 35.96%
Bright Health Group Inc. (BHG:NYSE), 33.33%
Livent Corporation (LTHM:NYSE), 30.25%
AIkido Pharma Inc. (AIKI:NASDAQ), 30.05%
BlueLinx Holdings Inc. (BXC:NYSE), 28.51%
Superior Industries International, Inc. (SUP:NYSE), 28.04%
U.S. Auto Parts Network, Inc. (PRTS:NASDAQ), 27.21%